LPS-induced brain inflammation resulted in activated microglial cells and enhanced levels of molecular markers of inflammation such as NFκB signaling pathway and its proinflammatory target proteins (TNF-α and COX-2). This evidence concerns the gene PTGS2 and brain inflammatory disease.